- ProPhase Labs (NASDAQ:PRPH) priced its underwritten public offering of 4.17M shares at $0.72 per share, for gross proceeds of ~$3M.
- Underwriters have a 45-day option to purchase up to an additional 625,500 shares.
- The offering is expected to close on November
ProPhase Labs plummets 21%, prices $3M equity offering (NASDAQ:PRPH)
